Literature DB >> 9361599

Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients.

B A van Wagensveld1, P P Coene, T M van Gulik, E A Rauws, H Obertop, D J Gouma.   

Abstract

BACKGROUND: Recent reports of decreased morbidity and mortality following palliative surgery for patients with irresectable pancreatic head carcinoma prompted a review of the results in 126 patients (median age 64 (range 39-90) years) who had undergone palliative biliary and gastric bypass surgery.
METHODS: The indication for surgical palliation was the finding of an irresectable tumour at laparotomy (n = 44), failure of endoscopic treatment (n = 43), clinical symptoms of gastric outlet obstruction (n = 28) and miscellaneous (n = 11). Biliary and gastric bypass was performed in 118 patients, biliary bypass alone in six and gastrojejunostomy alone in two. The indication for gastrojejunostomy was symptoms in 28 patients (23 per cent) and prophylaxis in 92 patients (77 per cent).
RESULTS: Postoperative local complications occurred in 17 per cent of patients, general complications in 10 per cent and delayed gastric emptying in 14 per cent of patients. The 30-day mortality rate was 1 per cent and overall hospital mortality rate 2 per cent. Median hospital stay was 17 (range 5-80) days. Median overall postoperative survival was 190 (range 14-830) days. Late obstructive gastrointestinal symptoms occurred in 14 patients (11 per cent) after a median of 141 (range 21-356) days.
CONCLUSION: Roux-en-Y hepaticojejunostomy combined with gastrojejunostomy offers effective palliation for irresectable pancreatic head cancer and can be performed with low mortality and acceptable morbidity rates.

Entities:  

Mesh:

Year:  1997        PMID: 9361599

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.

Authors:  Phillip J Gray; Jingya Wang; Timothy M Pawlik; Barish H Edil; Richard Schulick; Ralph H Hruban; Harry Dao; John Cameron; Christopher Wolfgang; Joseph M Herman
Journal:  J Surg Oncol       Date:  2012-02-03       Impact factor: 3.454

2.  Palliative surgery for unresectable pancreatic and periampullary cancer: a reappraisal.

Authors:  Mickael Lesurtel; Nidal Dehni; Emmanuel Tiret; Rolland Parc; François Paye
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

Review 3.  Surgical palliation in patients with pancreatic cancer.

Authors:  Jörg Köninger; Moritz N Wente; Michael W Müller; Carsten N Gutt; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2006-11-11       Impact factor: 3.445

4.  Surgical palliation of unresectable pancreatic head cancer in elderly patients.

Authors:  Sang Il Hwang; Hyung Ook Kim; Byung Ho Son; Chang Hak Yoo; Hungdai Kim; Jun Ho Shin
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

5.  Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer.

Authors:  Yasuhiro Fujino; Tetsuya Sakai; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

6.  Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.

Authors:  H Friess; L Wang; Z Zhu; R Gerber; M Schröder; A Fukuda; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

7.  Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.

Authors:  Peter J Kneuertz; Steven C Cunningham; John L Cameron; Sergio Torrez; Nicholas Tapazoglou; Joseph M Herman; Martin A Makary; Frederic Eckhauser; Jingya Wang; Kenzo Hirose; Barish H Edil; Michael A Choti; Richard D Schulick; Christopher L Wolfgang; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2011-09-13       Impact factor: 3.452

8.  Palliative surgical bypass for pancreatic and peri-ampullary cancers.

Authors:  Samrat Mukherjee; Hemant M Kocher; Robert R Hutchins; Satyajit Bhattacharya; Ajit T Abraham
Journal:  J Gastrointest Cancer       Date:  2007

9.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

10.  Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma.

Authors:  Els J M Nieveen van Dijkum; Mark G Romijn; Caroline B Terwee; Laurens Th de Wit; Jan H P van der Meulen; Han S Lameris; Erik A J Rauws; Huug Obertop; Casper H J van Eyck; Patrick M M Bossuyt; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.